|
|
Vaccine Detail
|
FluLaval Tetra |
| Vaccine Information |
- Vaccine Name: FluLaval Tetra
- Target Pathogen: Influenza virus
- Target Disease: Influenza (flu)
- Product Name: Quadrivalent Influenza Vaccine (Split Virion, Inactivated)
- Tradename: FluLaval Tetra
- Manufacturer: GlaxoSmithKline
- Type: Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: Canada
- Host Species for Licensed Use: Human
- Preservative: Thimerosal
- Allergen: Eggs
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Store at 2º to 8ºC (36º to 46ºF), do not freeze, protect from light.
- Approved Age for Licensed Use: 6 months of age and older.
- Description: FLULAVAL® TETRA is a quadrivalent split-virion, inactivated influenza vaccine prepared from virus grown in the allantoic cavity of embryonated hens’ eggs. The virus is inactivated with ultraviolet light treatment followed by formaldehyde treatment, purified by centrifugation and disrupted with sodium deoxycholate. (GSK: FluLaval Tetra)
|
| Host Response |
|
|
| References |
GSK: FluLaval Tetra: GSK: FluLaval Tetra vaccine information [http://ca.gsk.com/media/590283/flulaval-tetra.pdf]
|
|
